Search Result "SU5614"
FLT3 as a Therapeutic Target in Childhood Acute Leukemia
Journal: Current Drug Targets
Volume: 8 Issue: 6 Year: 2007 Page: 703-714
Author(s): Matthew C. Stubbs, Scott A. Armstrong
Strategies to Overcome Drug Resistance of Receptor Tyrosine Kinaseaddicted Cancer Cells
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 14 Year: 2014 Page: 1607-1617
Author(s): Flavio Maina
Indolinones as Promising Scaffold as Kinase Inhibitors: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 98-119
Author(s): C. R. Prakash, S. Raja
Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 3113-3132
Author(s): S. Schenone, C. Brullo, M. Botta
Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 2 Year: 2006 Page: 153-161
Author(s): Mark N. Kirstein, Megan M. Moore, Arkadiusz Z. Dudek
Review of Selected Patents for Cancer Therapy Targeting: Tumor Angiogenesis
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Mark N. Kirstein, Arkadiusz Z. Dudek
Doi: 10.2174/978160805161811001010741
Quantifying the Structural Requirements for Designing Newer FLT3 Inhibitors
Journal: Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2012 Page: 913-927
Author(s): Rajiv Kumar Kar,Priyanka Suryadevara,Rajesh Roushan,Ganesh Chandra Sahoo,Manas Ranjan Dikhit,Pradeep Das
Bench to Bedside Targeting of FLT3 in Acute Leukemia
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 781-789
Author(s): Keith W. Pratz, Mark J. Levis
Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa
Obesity and Asthma
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3 Issue: 3 Year: 2009 Page: 162-172
Author(s): Hans-Peter Hauber, Michael Wegmann